| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.922 | 43.722 | - | 87.554 | 124.978 | 135.221 | 199.157 | 245.313 | 308.863 | 354.529 |
| Total Income - EUR | 24.410 | 44.173 | - | 87.741 | 125.525 | 135.754 | 199.482 | 245.313 | 309.289 | 365.252 |
| Total Expenses - EUR | 13.101 | 12.367 | - | 16.302 | 29.712 | 29.405 | 36.648 | 33.238 | 37.186 | 80.036 |
| Gross Profit/Loss - EUR | 11.309 | 31.805 | - | 71.439 | 95.813 | 106.349 | 162.834 | 212.075 | 272.103 | 285.216 |
| Net Profit/Loss - EUR | 10.587 | 31.183 | - | 70.563 | 94.501 | 104.992 | 160.846 | 209.622 | 268.825 | 273.312 |
| Employees | 1 | 1 | - | 2 | 2 | 2 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Focusmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.984 | 4.933 | - | 4.761 | 14.878 | 13.978 | 13.064 | 12.498 | 11.855 | 11.188 |
| Current Assets | 23.472 | 27.559 | - | 69.582 | 150.797 | 92.230 | 148.916 | 198.524 | 328.368 | 421.488 |
| Inventories | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5.067 | 11.866 | - | 48.470 | 106.637 | 29.959 | 39.508 | 138.251 | 116.736 | 144.462 |
| Cash | 18.405 | 15.693 | - | 21.112 | 44.159 | 62.271 | 109.408 | 60.273 | 211.633 | 277.026 |
| Shareholders Funds | 27.400 | 31.250 | - | 70.628 | 163.761 | 105.054 | 160.907 | 209.682 | 336.869 | 422.548 |
| Social Capital | 56 | 56 | - | 54 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 1.056 | 1.242 | - | 3.715 | 1.914 | 1.154 | 1.073 | 1.340 | 3.355 | 10.127 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Focusmed Srl